CNH Industrial N.V. (NYSE:CNHI)
CNH Industrial NV designs, produces and sells trucks, commercial vehicles, buses, special vehicles, agricultural and construction equipment, in addition to engines and transmissions for those vehicles and engines for marine application. CNH Industrial NV is based in Amsterdam, the Netherlands.
CNH Industrial N.V. (NYSE:CNHI)’s Financial Overview
CNH Industrial N.V. (NYSE) surged 1.74% yesterday to close its trading session at $10.53. The company has 1 year Price Target of $12.45. CNH Industrial N.V. has 52-Week high of $14.5 and 52-Week Low of $8.41. The stock touched its 52-Week High on 14.50 and 52-Week Low on 8.41. The stock traded with the volume of 2.57 Million shares yesterday. The firm shows the market capitalization of $14.25 Billion.
CNH Industrial N.V. (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.16/share against the analyst consensus estimate of $0.13/share. The difference between the actual and expected EPS is $0.03 a share with a surprise factor of 23.1%.
The firm is trading with SMA20 of 4.76 Percent, SMA50 of 9.11 Percent and SMA200 of -3.38 percent. CNH Industrial N.V. has P/S value of 0.48 while its P/B value stands at 2.82. Similarly, the company has Return on Assets of 2.3 percent, Return on Equity of 23.2 percent and Return on Investment of 9.7 Percent. The company shows Gross Margin and Operating Margin of 22.1 percent and 11.1 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 2.6 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 20 analysts offering 12-month price forecasts for CNH Industrial NV have a median target of 12.52, with a high estimate of 17.40 and a low estimate of 8.00. The median estimate represents a +18.91% increase from the last price of 10.53.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM)’s Financial Outlook
The 11 analysts offering 12-month price forecasts for Tandem Diabetes Care Inc have a median target of 50.00, with a high estimate of 60.00 and a low estimate of 36.00. The median estimate represents a +7.64% increase from the last price of 46.45.
Tandem Diabetes Care, Inc. is expected* to report earnings on 02/26/2019 after market close. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.21. The reported EPS for the same quarter last year was $-1.23.
According to Zacks Investment Research, Tandem Diabetes Care, Inc. has a Consensus Recommendation of 1.7. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 4.69% and closed its last trading session at $46.45. The company has the market capitalization of $2.63 Billion. The stock has 52-week high of $52.55 and 52-Week low of $2.25. The firm touched its 52-Week high on 52.55 and 52-Week low on 2.25. The company has volume of 3.55 Million shares. The company has a total of 56.58 Million shares outstanding.
Tandem Diabetes Care, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.62/share where the analyst estimated EPS was $-0.34/share. The difference between the actual and Estimated EPS is $-0.28. This shows a surprise factor of -82.4 percent.
The company has YTD performance of 22.33 percent. Beta for Tandem Diabetes Care, Inc. stands at 0.5 while its ATR (average true range) is 2.4. The company has Weekly Volatility of 6.06%% and Monthly Volatility of 5.09%%.
Tandem Diabetes Care, Inc. has distance from 20-day Simple Moving Average (SMA20) of 8.18%, Distance from 50-Day Simple Moving Average of 19.92 percent and Distance from 200-Day Simple Moving Average of 48.54%.
The Company currently has ROA (Return on Assets) of -95 percent, Return on Equity (ROE) of -443.7 Percent and Return on Investment (ROI) of -241.7% with Gross margin of 44.4 percent and Operating & Profit margin of -40.6% and -93.1% respectively.